-+ 0.00%
-+ 0.00%
-+ 0.00%
Sotera Health Q2 net income rises to $54 million; net revenues increase 9.2% to $321.38 million vs Q2 2025
Share
Listen to the news
Sotera Health Q2 net income rises to $54 million; net revenues increase 9.2% to $321.38 million vs Q2 2025
  • Sotera Health Q2 net revenues rose 9.2% to USD 321.38 million from a year earlier.
  • Net income swung to USD 54 million, or USD 0.19 per diluted share.
  • Adjusted EBITDA (non-GAAP) increased 10% to USD 165.74 million, lifting margin 0.4 percentage points to 51.6%.
  • Segment net revenues climbed to USD 211.57 million at Sterigenics, USD 49.15 million at Nordion, USD 60.66 million at Nelson Labs.
  • Full-year net revenues outlook raised to USD 1.236 billion-USD 1.254 billion; adjusted EPS (non-GAAP) forecast lifted to USD 0.95-USD 1.01.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sotera Health Co. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending